Addressing Postprandial Glucose Excursions: An Update on the Implications and New Management Strategies for Patients with Diabetes

Despite demonstration of decreased cardiovascular risk with lowered postprandial glucose levels and the availability of fast-acting insulins to treat postprandial glucose excursions (PPGE), debate remains about the necessity of treating PPGE. It is critical that clinicians who manage patients with diabetes keep up to date with the latest emerging evidence for newer, ultra-fast-acting prandial insulins, as this is an evolving category. Whereas prandial insulin use primarily pertains to type 1 diabetes, a number of people with type 2 diabetes also benefit from prandial insulin. Endocrinologists and diabetes specialists need to understand how to tailor diabetes care according to individual patient backgrounds and characteristics, especially with respect to prandial insulin. They also require an understanding of the most recently updated guidelines about the appropriate use of prandial insulin therapy, and how patient factors influence selection of appropriate insulin regimens. This educational activity will address postprandial hyperglycemia and its treatment.


Please Note: this course is housed on My CME. Upon selecting 'Take Course,' you will be redirected to My CME to complete the activity.

Target Audience

This activity has been designed to address the educational needs of endocrinologists. It may also benefit diabetes specialists,
primary care physicians, hospitalists, certified diabetes educators, PAs, nurse practitioners (NPs), pharmacists, managed care clinicians, and other clinicians who care for patients with diabetes.

Learning Objectives

Upon proper completion of this activity, participants should be better able to:


• Discuss the implications of postprandial hyperglycemia for patients with diabetes.
• Describe how ultra-fast-acting insulins are used to mimic physiologic insulin for patients with diabetes.
• Outline appropriate use of ultra-fast-acting insulins for patients with diabetes.

Additional information
Available for MOC Points?: 
No
Practice Area: 
Diabetes
Course summary
Available credit: 
  • 1.75 AMA
  • 1.75 Attendance
Course opens: 
08/28/2018
Course expires: 
08/28/2019
Cost:
$0.00

Richard E. Pratley, MD (Chair)
Director and Samuel E. Crockett Chair in Diabetes Research
Florida Hospital Diabetes Institute
Senior Investigator and Diabetes Program Lead

Translational Research Institute for Metabolism and Diabetes
Adjunct Professor, Sanford Burnham Prebys Medical Discovery Institute
Orlando, FL

 

Bruce W. Bode, MD

Clinical Associate Professor

Division of Endocrinology, Metabolism and Lipids

Department of Medicine

Emory University

Atlanta, GA

Irl B. Hirsch, MD

Professor of Medicine

Diabetes Treatment and Teaching Chair

Division of Metabolism, Endocrinology and Nutrition

Department of Medicine

University of Washington

Seattle, WA

Guillermo E. Umpierrez, MD

Professor of Medicine

Department of Medicine

Emory University School of Medicine

Section Chief, Diabetes and Endocrinology Division

Grady Health System

Atlanta, GA

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.75 AMA
  • 1.75 Attendance

Accreditation Period

Course opens: 
08/28/2018
Course expires: 
08/28/2019

Price

Cost:
$0.00
Please login or register to take this course.